News & Updates

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

12 Jun 2025 by

A low-carbohydrate diet (LCD), particularly when its fat and protein sources are predominantly animal-based, may contribute to increased risk of bladder cancer among Chinese Singaporeans, according to new research.

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

12 Jun 2025

Timely rectal cancer treatment extends survival outcomes

12 Jun 2025

The timing of rectal cancer treatment is crucial in improving patient survival, according to a study.

Timely rectal cancer treatment extends survival outcomes

12 Jun 2025

SHR-A1811 shows promise vs HER2-positive breast cancer

12 Jun 2025 by

The third-generation human epidermal growth factor receptor 2 (HER2)-directed antibody‒drug conjugate (ADC) SHR-A1811 has passed its phase II trial, demonstrating safety and efficacy in the neoadjuvant setting for patients with HER2-positive breast cancer.

SHR-A1811 shows promise vs HER2-positive breast cancer

12 Jun 2025

$CAR T-cell therapy offers survival benefits in refractory B-cell ALL$

CAR T-cell therapy offers survival benefits in refractory B-cell ALL

12 Jun 2025

Chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukaemia (r/r B-ALL) demonstrates efficacy with high rates of durable remissions, as shown in a recent meta-analysis.

CAR T-cell therapy offers survival benefits in refractory B-cell ALL

12 Jun 2025

VTE event risk up in PD patients

12 Jun 2025 by

Researchers from Singapore found an elevated risk of venous thromboembolism (VTE) events in individuals with Parkinson’s disease (PD) in a systematic review and meta-analysis of 13 studies.

VTE event risk up in PD patients

12 Jun 2025

First-line osimertinib plus chemotherapy further extends PFS in advanced EGFR-mutated NSCLC

12 Jun 2025 by

The third-generation EGFR tyrosine kinase inhibitor (TKI), osimertinib, is preferred over earlier-generation EGFR TKIs as the first-line agent in patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). In an interview with MIMS Oncology, Dr James Ho, Specialist in Respiratory Medicine in Hong Kong, discussed the positive survival outcomes associated with first-line treatment with osimertinib plus chemotherapy together in patients with advanced EGFR-mutated NSCLC, and shared which patients may benefit from this upfront combination treatment strategy.

First-line osimertinib plus chemotherapy further extends PFS in advanced EGFR-mutated NSCLC

12 Jun 2025

Simvastatin confers no additional antidepressant benefit when added to escitalopram

12 Jun 2025

In patients with comorbid major depressive disorder (MDD) and obesity, adding simvastatin to escitalopram does not appear to produce additional antidepressive effects despite improving the cardiovascular risk profile, according to a study.

Simvastatin confers no additional antidepressant benefit when added to escitalopram

12 Jun 2025

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

12 Jun 2025

At the Asia Vaccines and Antivirals Summit (AVAS) 2025 held in Bangkok, Thailand, two expert-led sessions provided valuable perspectives on the expanding role of oral antivirals in COVID-19 management. Dr Daniel Griffin, an infectious disease specialist and Clinical Instructor of Medicine at Columbia University, New York, US, focused on protecting high-risk populations through the timely use of antiviral therapy. Complementing this, Professor Ching-Tai Huang of Chang Gung University and Memorial Hospital in Taiwan offered practical guidance on clinical management strategies, including patient risk stratification and therapeutic selection.

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

12 Jun 2025

GCSF plus prednisolone extends survival in severe alcohol-associated hepatitis

11 Jun 2025

The addition of granulocyte colony-stimulating factor (GCSF) to prednisolone results in improved steroid responsiveness and prolonged survival with fewer infections and new-onset complications among patients with severe alcohol-associated hepatitis (SAH), a study has shown.

GCSF plus prednisolone extends survival in severe alcohol-associated hepatitis

11 Jun 2025

Mulberry leaves plus water chestnut tea lowers blood glucose in borderline diabetes

11 Jun 2025 by

Individuals with borderline diabetes may benefit from drinking mulberry leaves and water chestnut husk (MW) tea, which has been shown in a Japan study to reduce insulin secretion and prevent spikes in blood glucose levels.

Mulberry leaves plus water chestnut tea lowers blood glucose in borderline diabetes

11 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

Timely rectal cancer treatment extends survival outcomes

Timely rectal cancer treatment extends survival outcomes

SHR-A1811 shows promise vs HER2-positive breast cancer

SHR-A1811 shows promise vs HER2-positive breast cancer

CAR T-cell therapy offers survival benefits in refractory B-cell ALL

CAR T-cell therapy offers survival benefits in refractory B-cell ALL

VTE event risk up in PD patients

VTE event risk up in PD patients

First-line osimertinib plus chemotherapy further extends PFS in advanced EGFR-mutated NSCLC

First-line osimertinib plus chemotherapy further extends PFS in advanced EGFR-mutated NSCLC

Simvastatin confers no additional antidepressant benefit when added to escitalopram

Simvastatin confers no additional antidepressant benefit when added to escitalopram

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

GCSF plus prednisolone extends survival in severe alcohol-associated hepatitis

GCSF plus prednisolone extends survival in severe alcohol-associated hepatitis

Mulberry leaves plus water chestnut tea lowers blood glucose in borderline diabetes

Mulberry leaves plus water chestnut tea lowers blood glucose in borderline diabetes